Repligen Corp
General ticker "RGEN" information:
- Sector: Health Care
- Industry: Life Sciences Tools & Services
- Capitalization: $8.4B
Repligen Corp does not follow the US Stock Market performance with the rate: -15.9%.
Estimated limits based on current volatility of 3.0%: low 142.82$, high 151.71$
Factors to consider:
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [128.30$, 204.64$]
- 2024-12-30 to 2025-12-30 estimated range: [130.15$, 207.38$]
Financial Metrics affecting the RGEN estimates:
- Positive: 0.93 < Non-GAAP EPS, $ of 1.73
- Negative: Operating cash flow per share per price, % of 1.21 <= 2.35
- Positive: 1.03 < Operating profit margin, % of 8.54
- Positive: -0.25 < Return on assets ratio (scaled to [-100,100]) of 1.45
- Negative: Industry operating profit margin (median), % of -12.70 <= 2.14
- Negative: Industry inventory ratio change (median), % of 1.54 > 0.49
- Negative: Industry earnings per price (median), % of -3.50 <= 1.31
- Negative: Industry operating cash flow per share per price (median), % of 0.50 <= 3.85
- Positive: -3.48 < Investing cash flow per share, $ of -2.21
Short-term RGEN quotes
Long-term RGEN plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $670.53MM | $801.54MM | $638.76MM |
| Operating Expenses | $503.29MM | $576.87MM | $584.19MM |
| Operating Income | $167.25MM | $224.67MM | $54.58MM |
| Non-Operating Income | $-13.71MM | $-5.53MM | $9.56MM |
| Interest Expense | $12.71MM | $1.16MM | $10.03MM |
| R&D Expense | $34.27MM | $43.94MM | $42.72MM |
| Income(Loss) | $153.54MM | $219.14MM | $64.13MM |
| Taxes | $25.25MM | $33.18MM | $22.55MM |
| Profit(Loss) | $128.29MM | $185.96MM | $41.58MM |
| Stockholders Equity | $1,750.07MM | $1,910.70MM | $1,971.20MM |
| Assets | $2,358.35MM | $2,524.66MM | $2,824.41MM |
| Operating Cash Flow | $119.02MM | $172.08MM | $113.92MM |
| Capital expenditure | $71.28MM | $133.35MM | $38.99MM |
| Investing Cash Flow | $-221.17MM | $-233.24MM | $-123.28MM |
| Financing Cash Flow | $0.96MM | $-13.34MM | $248.96MM |
| Earnings Per Share* | $2.33 | $3.35 | $0.75 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.